tm logo
Trademark Search
INRAYUS

View On IC.GC.CA

INRAYUS
CANCELLED

on 31 Dec 1969

Last Applicant/ Owned by

Sumitomo Pharma America, Inc.

84 Waterford DriveMarlborough MA 01752

US

Serial Number

2125162 filed on 19th May 2021

Registration Number

TMA1170314 registered on 08th Mar 2023

Registration expiry Date

19th May 2031

Correspondent Address

33 Yonge Street, Suite 300Toronto

ONTARIO

CA

M5E1G4

INRAYUS

Trademark usage description

pharmaceutical preparations for treating central nervous system diseases or disorders; pharmaceutical preparations for treating schizophrenia; pharmac Read More

Classification Information

Class [005]
Pharmaceutical preparations for treating central nervous system diseases or disorders; pharmaceutical preparations for treating schizophrenia; pharmaceutical preparations for treating cognitive disorders.

Classification kind code

11

Mark Details

Serial Number

2125162

Mark Type

Trademark

Legal History

Show more

Action TakenStatus
Submitted for opposition 222
on 19th Dec 2022		Opposition Start Date Notice Sent
Submitted for opposition 26
on 24th Nov 2022		Approved
Submitted for opposition 27
on 24th Nov 2022		Approval Notice Sent
Submitted for opposition 22
on 18th Nov 2022		Search Recorded
Submitted for opposition 48
on 22nd Jun 2022		Agent Changed
Submitted for opposition 256
on 06th Jun 2022		Notification of Possible Opposition Sent
Submitted for opposition 257
on 05th Aug 2021		Designation Notification - Madrid Protocol
Submitted for opposition 1
on 04th Aug 2021		Created
Submitted for opposition 31
on 04th Aug 2021		Formalized
Submitted for opposition 30
on 19th May 2021		Filed